MA
Mario Alberto Accardi
Chief Executive OfficerDirector

Mario Alberto Accardi insider trades: Centessa Pharmaceuticals (CNTA) stock sales

Chief Executive Officer, Centessa Pharmaceuticals Last trade Dec 9, 2025 12 Form 4 filings
$588K
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2025
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Mario reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 9, 2025CNTA↓ Sell$288K
Dec 8, 2025CNTA↓ Sell$300K
Oct 27, 2025CNTA↓ Sell$200K
Sep 16, 2025CNTA↓ Sell$175K
Sep 9, 2025CNTA↓ Sell$140K
Jul 29, 2025CNTA↓ Sell$127K
Jun 24, 2025CNTA↓ Sell$210K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CNTA insiders

Open-market trades in the last 12 months

About Mario Alberto Accardi's insider trades

Mario Alberto Accardi is Chief Executive Officer at Centessa Pharmaceuticals (CNTA). Since Jun 24, 2025, Mario has reported no open-market purchases and 7 sales worth $1.4M on SEC Form 4. In the last 12 months: 2 sales ($588K).

Their filings also include shares withheld for taxes (4 filings), option exercises (4 filings), shares returned to the company (1 filing), grants and awards (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CNTA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.